AI-Enhanced Healthcare: Integrating ChatGPT-4 in ePROs for Improved Oncology Care and Decision-Making: A Pilot Evaluation
Current Oncology · 2024
DOI: 10.3390/curroncol32010007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2024. Verfasst von Chihying Liao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, China Medical University Hospital, Taichung City 404, Taiwan. Hauptthemen laut MEDLINE: Medical Oncology, Neoplasms, Artificial Intelligence, Patient Reported Outcome Measures. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Medical University Hospital.
Abstract (Originalsprache)
Background
Since 2023, ChatGPT-4 has been impactful across several sectors including healthcare, where it aids in medical information analysis and education. Electronic patient-reported outcomes (ePROs) play a crucial role in monitoring cancer patients’ post-treatment symptoms, enabling early interventions. However, managing the voluminous ePRO data presents significant challenges. This study assesses the feasibility of utilizing ChatGPT-4 for analyzing side effect data from ePROs.
Methods
Thirty cancer patients were consecutively collected via a web-based ePRO platform, reporting side effects over 4 weeks. ChatGPT-4, simulating oncologists, dietitians, and nurses, analyzed this data and offered improvement suggestions, which were then reviewed by professionals in those fields.
Results
Two oncologists, two dieticians, and two nurses evaluated the AI’s performance across roles with 540 reviews. ChatGPT-4 excelled in data accuracy and completeness and was noted for its empathy and support, enhancing communication and reducing caregiver stress. It was potentially effective as a dietician.
Discussion
This study offers preliminary insights into the feasibility of integrating AI tools like ChatGPT-4 into ePRO cancer care, highlighting its potential to reduce healthcare provider workload. Key directions for future research include enhancing AI’s capabilities in cancer care knowledge validation, emotional support, improving doctor-patient communication, increasing patient health literacy, and minimizing errors in AI-driven clinical processes. As technology advances, AI holds promise for playing a more significant role in ePRO cancer care and supporting shared decision-making between clinicians and patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, China Medical University Hospital, Taichung City 404, Taiwan.
- Graduate Institute of Clinical Medical Science, China Medical University, Taichung City 404, Taiwan.
- Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung City 404, Taiwan.
- Department of Surgery, China Medical University Hospital, Taichung City 404, Taiwan.
- Department of Medicine, China Medical University, Taichung City 404, Taiwan.
ORCID-Profile: Chihying Liao
Förderung
- China Medical University Hospital
Zitieren
APA
Liao, C., Chu, C., Lien, M., Wu, Y., & Wang, T. (2024). AI-Enhanced Healthcare: Integrating ChatGPT-4 in ePROs for Improved Oncology Care and Decision-Making: A Pilot Evaluation. Current Oncology. https://doi.org/10.3390/curroncol32010007
Vancouver
Liao C, Chu C, Lien M, Wu Y, Wang T. AI-Enhanced Healthcare: Integrating ChatGPT-4 in ePROs for Improved Oncology Care and Decision-Making: A Pilot Evaluation. Current Oncology. 2024. doi:10.3390/curroncol32010007
BibTeX
@article{Liao2024,
author = {Liao, Chihying and Chu, Chinnan and Lien, Mingyu and Wu, Yaochung and Wang, Tihao},
title = {AI-Enhanced Healthcare: Integrating ChatGPT-4 in ePROs for Improved Oncology Care and Decision-Making: A Pilot Evaluation},
journal = {Current Oncology},
year = {2024},
doi = {10.3390/curroncol32010007}
}
EUVIMED